Lab Naprovid

3 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• NO ENGLISH2 refused lines

  Required label information not in English

  Information that must appear on the label appeared not to be given in English, or not to be repeated in every language used on the label.

• NCONTACT1 refused line

  No U.S. adverse event contact on supplement label

  The dietary supplement label appeared not to show a U.S. address or phone number through which a serious adverse event can be reported.

• NUTRIT LBL1 refused line

  Nutrition information missing from label

  The label or labeling appeared not to carry the nutrition information that U.S. law requires for the food.

• UNAPPROVED1 refused line

  Unapproved new drug

  The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.

Questions about Lab Naprovid

Is Lab Naprovid on an FDA import alert?

Yes. As of October 26, 2026, Lab Naprovid is on the red list of FDA Import Alert 54-16, “Foods/supplements with active pharmaceutical ingredient”, for contra reumas suplemento alimenticio (against rheumatism dietary supplement); FDA published the listing on June 22, 2026.

Has FDA refused shipments from Lab Naprovid?

Yes. FDA refused 2 shipment lines from Lab Naprovid on August 13, 2025. The most recent, on August 13, 2025, was herbals & botanicals (not teas), n.e.c., charged as NO ENGLISH (required label information not in english).

Why did FDA refuse Lab Naprovid's shipments?

The most frequent charges are NO ENGLISH (required label information not in english, 2 lines) and NCONTACT (no u.s. adverse event contact on supplement label, 1 line).

What is Lab Naprovid's FEI number?

Lab Naprovid's FDA Establishment Identifier (FEI) is 3031120658.

Can shipments from Lab Naprovid still enter the U.S.?

Shipments of contra reumas suplemento alimenticio (against rheumatism dietary supplement) from Lab Naprovid can be detained without physical examination under Import Alert 54-16; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).